Bayer’s CEO flattened the company. Now comes the hard part

Key Topics in this News Article:
News Snapshot:

“Our ambition, for the last three years, basically, was to survive,” he told me, as we sipped takeout coffee in an empty corner of New York’s Javits Center last month. “How much are we willing to stretch ourselves now and put out a bold ambition for what this company can be and fight for that?” Good question. Bayer announced plans to invest $2.2 billion in a new Ohio manufacturing site last week. Global COO Sebastian Guth recently wrote in Fortune that the company stopped assigning sales targets. Investors are newly enthusiastic as Bayer’s stock is up 57% over the past…

  • This field is for validation purposes and should be left unchanged.
  • Newsletter to Your Inbox

    China intelligence delivered each week!